ArticleMolecular cancer therapeutics2009

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.

M Pia Morelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.